Ashour, Reham
Ri, Masaki http://orcid.org/0000-0002-9617-486X
Aly, Sanaa Shaker
Yoshida, Takashi
Tachita, Takuto
Kanamori, Takashi
Aoki, Sho
Kinoshita, Shiori
Narita, Tomoko
Totani, Haruhito
Masaki, Ayako
Ito, Asahi
Kusumoto, Shigeru
Komatsu, Hirokazu
Mansour, Samar
Elsaied, Abdelrahman A.
Iida, Shinsuke
Funding for this research was provided by:
Japan Agency for Medical Research and Development (15ck0106077h0002)
Bristol-Myers Squibb
Ministry of Higher Education, Egypt (Cultural Affairs Sector, Missions)
Ministry of Education, Culture, Sports, Science and Technology (16K07179)
Ministry of Education, Culture, Sports, Science, and Technology (16K09855)
National Cancer Center Research and Development (26-A-4)
Article History
Received: 19 December 2018
Revised: 8 April 2019
Accepted: 11 April 2019
First Online: 21 May 2019
Compliance with ethical standards
:
: MR received research funding from Celgene Co., Ltd. SI received research funding and declares Honoraria from Janssen Pharmaceutical K.K., and Celgene Co., Ltd. SI also received research funding from Kyowa Hakko Kirin Co., Ltd., Chugai Pharmaceutical Co., Ltd, Bristol-Myers Squibb, Takeda Yakuhin Co., Ltd., and Ono Pharmaceutical CO., Ltd.